Having trouble viewing this email? View in your browser.

5 February 2019

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,

ESCMID Executive Office.


ECCMID 2019 Keynote: Jean-Michel Molina on PReP

Don’t miss out on the ECCMID Keynote Lecture ‘Pre-exposure prophylaxis in sexually transmitted infections, HIV and other situations: a change in mind in the prevention of infections?’ – presented by Prof. Jean-Michel Molina. Prof. Molina has been involved in a number of studies assessing new drugs or new strategies for the treatment of HIV infection, and a cohort of more than 4,000 patients with HIV infection is followed in his department.

Be sure to register online for ECCMID, and check out the rest of the programme, including the other fascinating keynotes!

› Read more

New deadline for becoming a member of the ESCMID Parity Commission

ESCMID is happy to announce that the call for two positions in the ESCMID Parity Commission is still open!

The new deadline is 28 February 2019.

The officer’s term is envisaged as 3 years (2019-2021) with the possibility of a two-year extension. The new members will collaborate with other members of the Parity Commission under the guidance of the ESCMID president–elect and secretary general. ECCMID registration, accommodation and travel costs, as well as costs incurred for any other Parity Commission meeting will be reimbursed by ESCMID. Eligible for the position are ESCMID members who are passionate about issues regarding parity and equity in the CM/ID professional area. Please visit the ESCMID Parity Commission webpage to see the call document and to have an overview of the activities of the ESCMID Parity Commission.

To apply for this position please send an email with your CV and cover letter to

› Read more

ESGBIES/CTCB programme to evaluate and promote quality improvement of blood culture in Europe

Evaluate how properly performed blood culture is in your hospital!
With the aim of promoting quality improvement of blood culture test method, the ESCMID study group for bloodstream infection, endocarditis and sepsis (ESGBIES) and the Centre Toulousain pour le Contrôle de qualité en Biologie Clinique (CTCB) have initiated a cooperation to provide a novel programme open to any lab in Europe. We are excited to announce the programme has started early January.

The programme aims to evaluate the preanalytical phase of blood culture for adult patients. The evaluated parameters include for instance the volume of blood per bottle, the number of bottle cultured over 24h, and the rate of contamination. Level of laboratory performance will be compared to peer groups. Secondary objectives includes the identification of determinants of quality default. Overall, it should help every lab in promoting quality of the preanalytical phase of blood culture, of patient management (and accreditation). The programme is free of charge.

Each participating lab will collect data for 50 episodes in adult patients from whom blood culture were collected. Some basic background information on blood culture practice and on institution characteristics should also be provided to ensure accurate analysis. Lab information will be anonymized and a fast feedback of results will be provided to every lab.

Depending on the results obtained and on participation rate, a second step may be proposed to volunteer labs. Step 2 would include the same evaluation than step 1 after actions of improvement are taken (actions of improvement will be suggested to participating labs at the end of step 1). Labs are free to participate to step 1 only, but labs who would like to participate to step 2 must have participated to step 1.

Practical details:
- Start: 7 January 2019
- Step 1 ends on 17 March 2019
- Step 2 start: to be defined, depends on results of step 1 study.
- Material: detailed instructions provided (link below). Excel form to be filled and sent to CTCB for analysis
- More information at CTCB website
- Contact: Brigitte Lamy - brigitte_lamy@yahoo.fr

› Read more

ISID/ESCMID Fellowship Program

ESCMID and the International Society of Infectious Diseases (ISID) collaborate on the ISID/ESCMID Fellowship Program that enables young investigators, from low and low-middle income countries outside of the region, to travel to Europe for multidisciplinary clinical and laboratory training.

Applications for this fellowship close on April 1, 2019.

You can find out more and apply on the ISID website.

› Read more

Launch of Europe-wide survey of healthcare workers’ knowledge and attitudes about antibiotic use and resistance

On 28 January 2019, an ECDC-funded survey to assess healthcare workers’ knowledge and perceptions about antibiotic use and resistance launched across Europe. Previous studies have mostly focused on the general public and medical students, highlighting a gap in the understanding of these topics by healthcare workers and by other health students.

Following a process of validation and piloting across Europe, the survey is now available for completion. 

The study closes on 14 February 2019.

› Read more

CMI highlight: Concurrent cerebral aspergillosis and abdominal mucormycosis during Ibrutinib therapy for chronic lymphocytic leukemia.

Peri et al reported a case of invasive aspergillosis with primary pulmonary involvement followed by central nervous system (CNS) involvement in a patient treated for chronic lymphocytic leukemia (CLL) with ibrutinib.

In addition to their work, the author describes a case of primary involvement of CNS aspergillosis and abdominal mucormycosis in a patient treated with ibrutinib.

The authors stated that the emerging fungal syndrome in CLL patients receiving ibrutinib justified the need for a comprehensive review of extrapulmonary disease and invasive diagnostic procedures for the risk of disseminated fungal co-infection.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Phone +41 61 5080 173
Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.